Co-Diagnostics (NASDAQ: CODX), a molecular Diagnostics Company focused on developing nucleic acid molecule based reagents for diagnostic tests, announced the successful initial verification of its screening test, used for detecting the presence of the novel coronavirus. The polymerase chain reaction (PCR) screening test will soon...
OptimizeRx Corporation (NASDAQ: OPRX), a pioneer in the cloud-based digital health messaging solutions arena that create a bridge between pharmaceutical Companies and healthcare providers, announced the signing of its largest ever enterprise deal for 12 months of access to its platform and core set of...
According to the World Health Organization (WHO), Coronovirus (CoV) is a family of viruses that cause illnesses ranging from common cold to lethal diseases such as the Middle East Respiratory Syndrome (MERS-CoV), Severe Acute Respiratory Syndrome (SARS-CoV) and a new strain of CoV named, novel...
iAnthus Capital Holdings (OTCQX: ITHUF), a multistate cannabis operator with cultivation, processing and over 30 dispensary facilities in 11 states in the U.S, has received approval from the Massachusetts Cannabis Control Commission, to grow and process recreational-use cannabis. The Company will commence its operations for...
ReposiTrak (Park City Group (NASDAQ: PCYG)), an out-of-specification (OOS) Management Solution which addresses one of the most critical issues of retail management, announced that The Food Industry Association (FMI) is working with the Company to tackle the challenges of out-of-stocks that act as a challenge...
Concert Pharmaceuticals (NASDAQ: CNCE), a clinical stage biopharmaceutical Company, announced the receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for patent application No. 16/098,338 related to CTP-543, its lead candidate for the treatment of alopecia areata. The patent covers pharmaceutical...
Inovio Pharmaceuticals (NASDAQ: INO), a late-stage biotechnology Company developing DNA-based immunotherapies and vaccines to combat cancer and infectious diseases, announced the grant of up to $9 million by the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a vaccine for Coronavirus 2019-nCoV, a deadly new...
Melinta Therapeutics (NASDAQ: MLNT), a commercial-stage pharmaceutical Company, engaged in developing therapeutic options for treatment of bacterial infectious diseases, filed for Chapter 11 bankruptcy in January 2020. The Company had concerns about its financial prospects and warned the investors that it would be difficult to...
Inhibitor Therapeutics (OTCQB: INTI), a Biopharmaceutical Company focussed on addressing the unmet medical needs in the field of cancerous and non-cancerous proliferation disorders, announced the receipt of an Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for traconazole, intended for...
Innovative Solutions and Support (NASDAQ: ISSC), a manufacturer of Flight guidance and cockpit display system, announced the signing of a multi-year agreement with an Original Equipment Manufacturer for its ThrustSense® auto-throttle, to be included as standard equipment as part of new aircraft production. The system...
